TANHA PITZ: Open Payments
NPI 1396451928 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $231 |
| AstraZeneca Pharmaceuticals LP | 7 | $218 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $101 |
| GENZYME CORPORATION | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| BioCryst US Sales Co., LLC | 1 | $33 |
| Ionis Pharmaceuticals, Inc. | 1 | $30 |
| Grifols USA, LLC | 1 | $28 |
| CSL Behring | 1 | $23 |
Products named: NUCALA, TEZSPIRE, DUPIXENT, NEFFY, Rhapsido, ORLADEYO, DAWNZERA, Xembify.
Industry payments across CA — which companies pay providers there.
